Search

Your search keyword '"Duarte, Patricio"' showing total 48 results

Search Constraints

Start Over You searched for: Author "Duarte, Patricio" Remove constraint Author: "Duarte, Patricio"
48 results on '"Duarte, Patricio"'

Search Results

1. 'La Casa de las Flores': arquitectura urbana-manifiesto de Secundino Zuazo

2. Survival analysis of transplant-eligible newly-diagnosed multiple myeloma patients harboring t(4;14), t(14;16), and/or del(17p) in the real-world setting

3. Predicting Mortality after Autologous Transplant: Development of a Novel Risk Score

4. High Doses of Chemotherapy and Autologous Hematopoietic STEM Cell Transplantation in Patients with Relapsed/Refractory Testicular GERM Cell Tumors. Multicenter Real-World Experience in Argentina.

8. High doses of chemotherapy and autologous hematopoietic stem cell transplantation in patients with relapsed/refractory testicular germ cell tumors: Multicenter real-world experience in Argentina.

9. Letermovir Primary Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplant Recipients: Real-Life Data from a University Hospital in Argentina.

10. Survival analysis of transplant-eligible newly-diagnosed multiple myeloma patients harboring t(4;14), t(14;16), and/or del(17p) in the real-world setting

11. Primary plasma cell leukemia in Latin America: demographic, clinical, and prognostic characteristics. A study of GELAMM group

12. Multiple Myeloma Patients Aged 40 Years and Younger Have the Same Prognosis As Older Patients in an Analysis of Real-World Evidence from Latin America: A Study of 1,316 Patients from the Gelamm Latin American Multiple Myeloma Studygroup

13. Primera experiencia sobre efectividad y seguridad de lenalidomida-bortezomib- dexametasona (RVd) como tratamiento de inducción en pacientes con diagnóstico reciente de mieloma múltiple (MM) candidatos a trasplante hematopoyético en Argentina. Estudio colaborativo del Grupo Argentino de Mieloma Múltiple (GAMM).

14. Treatment and Survival Outcomes of Waldenstrom Macroglobulinemia in Latin American Patients: A Multinational Retrospective Cohort Study

15. P-151: Primary plasma cell leukemia in Latin America: demographic, clinical, and prognostic characteristics. A study of GELAMM group

16. P-176: Effect of induction regimen in survival in newly diagnosed multiple myeloma patients receiving consolidation with autologous stem cell transplantation

17. L’Enseignement Supérieur au Mozambique : une analyse de l’orientation scolaire des femmes et des hommes dans les filières universitaires de Licence

19. Survival of Patients with Multiple Myeloma Treated with Bortezomib-Based Triplets and Autologous Hematopoietic Stem Cell Transplant As First Line in Latin America

21. Real-world outcomes for the treatment of relapsed/refractory multiple myeloma patients with lenalidomide-dexamethasone combinations in a Latin American country. A retrospective cohort study from grupo argentino de mieloma múltiple

23. Different outcomes for transplant-eligible newly diagnosed multiple myeloma patients in Latin America according to the public versus private management: a GELAMM study

24. Real world outcomes with Bortezomib Thalidomide dexamethasone and Cyclophosphamide Bortezomib dexamethasone induction treatment for transplant eligible multiple myeloma patients in a Latin American country. A Retrospective Cohort Study from Grupo Argentino de Mieloma Múltiple

25. Violence Against Women and Girls in Public Spaces in Maputo: an Exploratory Study

26. Gammapatías monoclonales

27. Unequal Outcomes in Transplant Eligible Patients with Multiple Myeloma in Latin America: Differences between Public and Private Centers

28. Real World Outcomes in Latin-American Patients with Multiple Myeloma Under 40 Years Old

29. Early mortality in Transplant-eligible Multiple Myeloma patients in Latin America. An International Study of GELAMM.

30. CBeV (cyclophosphamide, bendamustine and etoposide) pre-autotransplant conditioning in persons with lymphoma

31. COAGULOPATÍA Y COVID-19. RECOMENDACIONES PARA UNA REALIDAD CAMBIANTE.

32. Real World Outcomes with VTD and Cybord Induction Treatment for Transplant Eligible Multiple Myeloma Patients in a Latin American Country. Retrospective Cohort Study from Gamm (Grupo Argentino de Mieloma Multiple)

35. Autologous Stem Cell Transplantation (ASCT) with Benda-CV (Bendamustine, Cyclophosphamide, Etoposide) in Non-Hodgkin (non-HO) and Hodgkin (HL) Lymphoma Patients (pts)

36. Haploidentical transplant in adult patients with acute lymphoblastic leukemia in Argentina: a comparison with matched related and unrelated donors

45. The Latin-American Experience in POEMS Syndrome: A Study of the GELAMM (Grupo de Estudio Latinoamericano de Mieloma Múltiple)

46. Patients Age 40 Years and Younger With Multiple Myeloma Have the Same Prognosis as Older Patients: An Analysis of Real-World Patients' Evidence From Latin America.

47. [Coagulopathy and COVID-19. Recommendations for a changing reality].

48. [Spontaneous spleen rupture associated to active cytomegalovirus infection].

Catalog

Books, media, physical & digital resources